Thymosin Alpha-1 (Tα1): Details & Benefits

1. Basic Introduction

Thymosin alpha-1 (Tα1) is a 28-amino-acid bioactive peptide (molecular weight: ~3 kDa) naturally produced by thymic epithelial cells. It is derived from the cleavage of prothymosin α (ProTα), a 109–113 amino acid precursor protein.

• Generic name: Thymalfasin
• Brand name: Zadaxin (approved in 35+ countries)
• Discovery: First isolated from thymus tissue in 1966; fully sequenced and synthesized in the 1970s.

2. Core Mechanism of Action

Tα1 acts as a potent immune modulator by targeting toll-like receptors (TLR2, TLR3, TLR4, TLR9) on immune cells (dendritic cells, macrophages, T/B cells, NK cells):

1. Promotes T-cell development: Drives differentiation of immature T cells into CD4⁺ helper and CD8⁺ cytotoxic T cells.
2. Boosts innate immunity: Activates NK cells and macrophages to enhance pathogen/killer cell activity.
3. Stimulates cytokine release: Increases production of IFN-γ, IL-2, IL-3, and TNF-α, amplifying immune signaling.
4. Restores immune homeostasis: Balances immune responses, suppressing excessive inflammation while fighting infection.

3. Key Benefits & Therapeutic Uses

① Antiviral Activity

• Hepatitis B/C: Approved in many countries for chronic hepatitis B/C; enhances viral clearance by restoring T-cell immunity (often combined with interferon).
• COVID-19 & Other Viruses: Reduces severity and mortality in viral infections by reversing virus-induced T-cell exhaustion.

② Antitumor Adjuvant

• Chemo/Radiotherapy Support: Protects bone marrow and immune cells from cytotoxic damage; reduces side effects (e.g., myelosuppression) and improves quality of life.
• Immunotherapy Synergy: Enhances efficacy of PD-1/PD-L1 inhibitors by reversing tumor microenvironment immunosuppression.
• Anti-metastatic: Inhibits tumor cell migration and angiogenesis; induces apoptosis in cancer cells.

③ Immune Deficiency & Aging

• Immune Senescence: Restores thymic function in elderly individuals, reversing age-related immune decline.
• Chronic Infections: Treats recurrent bacterial/fungal infections in immunocompromised patients (e.g., post-surgery, HIV).

④ Anti-Inflammatory & Organ Protection

• Autoimmune Diseases: Modulates Treg cells to suppress overactive immunity in conditions like rheumatoid arthritis.
• Organ Injury: Protects liver, lung, and kidney tissues from oxidative stress and inflammation.

4. Safety & Administration

• Route: Subcutaneous injection (most common); intravenous infusion.
• Side Effects: Mild and rare (injection site redness, fatigue, headache); no severe toxicity reported.
• Contraindications: Hypersensitivity to Tα1; active autoimmune disease (uncontrolled).

5. Summary

Thymosin alpha-1 is a multifunctional immune peptide with decades of clinical validation. Its core value lies in restoring, enhancing, and balancing immunity, making it a cornerstone therapy for viral infections, cancer supportive care, and immune deficiency disorders.

Research Use Only. This catalog information is reproduced from the customer legacy website. Products are not for human or veterinary use. Confirm current specification, availability and documentation before ordering.